在急性心力衰竭中,静脉注射Furosemide对血压的影响和低血压的风险
Nicholas E Harrison1, Meghana Bhaskara1, Kyle Wilson1
1Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
概括
在急性不补偿性心力衰竭 (ADHF) 患者中,静脉注射富洛塞米德 (IVFu) 后,静脉血压 (SBP) 略有下降. 低血压是罕见的和短暂的,大多数SBP变化归因于其他治疗因素.
科学领域:
- 心脏病学
- 药理学
- 临床医学
背景情况:
- 治疗急性不补偿性心力衰竭 (ADHF) 通常涉及静脉注射的利尿剂,如西米德 (IVFu).
- 了解IVFu对系统血压 (SBP) 和低血压风险的影响对于ADHF治疗期间的患者安全至关重要.
研究的目的:
- 量化IVFu对ADHF患者SBP的不良影响.
- 将IVFu对SBP的影响与ADHF治疗期间的其他因素进行比较.
主要方法:
- 在253名ADHF患者的前性多中心研究中,持续监测血压.
- 多变量调整的混合效应回归分析,以评估因IVFu而导致的SBP降低和低血压风险.
主要成果:
- 使用IVFu仅与小比例 (1. 4%) 的SBP变异和小程度的低血压风险 (1. 7%) 相关.
- 在80mgIVFu后,平均SBP下降为-11. 9mmHg,在基线SBP≥120mmHg时,低血压风险较低 (<2%).
- 与IVFu相关的低血压风险是剂量依赖的和短暂的,在服用后6小时内恢复为零.
结论:
- 在ADHF中,IVFu后的血压降低是适度的.
- 低血压是IVFu在ADHF中的罕见和暂时的不良反应.
- 在ADHF治疗期间,IVFu治疗之外的其他因素显著影响SBP变异性.
相关概念视频
Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Hemodialysis II: Procedure and Complications
128
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
128
Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152


